Emergent plans to triple anthrax vaccine production
January 21, 2014Manufacturing and Production Emergent BioSolutions, FDA, anthrax, biothrax
Emergent BioSolutions is planning a major expansion of manufacturing capacity for its anthrax vaccine BioThrax to meet the biodefense objectives …
Herceptin biosimilar set for Indian market
January 21, 2014Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab
Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …
AbbVie advances oncology drug
January 21, 2014Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib
AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer. This …
Roche schizophrenia drug fails
January 21, 2014Research and Development, Sales and Marketing Roche, biopertin, schizophrenia
Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …
Manufacturing news in brief
January 21, 2014Manufacturing and Production BASF, Heidelberg CSAT, Markem-Imaje, SEPIPROD and Micro-Sphere/NanoMaterials Technology, SPL, Shenzhen Hepalink
Shenzhen Hepalink buys SPL and Markem-Imaje takes over Heidelberg CSAT, plus a new science park in the UK and updates …
Novasep adds president to complete its executive team
January 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nieuwenhove, Novasep
Thierry Van Nieuwenhove has joined contract manufacturing organisation Novasep as president of its Synthesis business unit. Educated as a bio-engineer, Van …
Actavis makes Aurobindo sale
January 21, 2014Sales and Marketing Actavis, Aurobindo, India, generics
Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …
Government sugar tsar works for Coca-Cola and Mars
January 20, 2014Sales and Marketing UK government, action on sugar, macdonald
It has been revealed that the man tasked by the UK government to help implement tougher regulation on sugar levels …
Ranbaxy quality issues hit sixth plant; seeks Diovan workaround
January 20, 2014Manufacturing and Production FDA, Ranbaxy, fines, manufacturing
Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …
Merck recalls Liptruzet on packaging defects
January 20, 2014Manufacturing and Production FDA, Merck, US, liptruzet, recall
Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …
J&J to sell division for $4.1 billion
January 20, 2014Sales and Marketing Diagnostics, J&J, JJ, carlyle, ocd, ortho-clinical
Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …
Shire sheds Dermagraft at $650m loss
January 20, 2014Sales and Marketing Organogenesis, Shire, dermagraft
Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …
Problems and solutions
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, culture, pharma, problems, social media
Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …
New chair for British Generic Manufacturers Association
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bgma, thomas broeer
Thomas Broeer has been elected as chair of 





The British Generic Manufacturers Association (BGMA). Broeer, managing director of Kent Pharmaceuticals, …
Europe nod for Gilead HCV pill
January 20, 2014Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi
Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …
Google to use contact lens as diabetes monitor
January 17, 2014Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens
Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …
Actavis: China is ‘too risky’
January 17, 2014Sales and Marketing Actavis, China, bribery, generics, risky
The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …
Technology to dominate 2014 for businesses
January 17, 2014Medical Communications 2014, Cloud Computing, IT, digital, e-zest, technology
2014 will see healthcare businesses and governments rapidly absorb new technologies in order to enhance user experience and foster innovation …
Ian Gilham appointed chairman of the board at Horizon Discovery




January 17, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development Gilham, Horizon Discovery
Research tools firm Horizon Discovery has appointed Dr Ian Gilham as chairman of its board of directors.



 Gilham’s healthcare industry …
Gene trial ‘restores sight’
January 17, 2014Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes
A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
